These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12962779)

  • 1. Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation interferon-alpha2b monotherapy.
    González-Roncero F; Gentil MA; Valdivia MA; Algarra G; Pereira P; Toro J; Sayago M; Mateos J
    Transplant Proc; 2003 Aug; 35(5):1745-7. PubMed ID: 12962779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy.
    Izopet J; Rostaing L; Moussion F; Alric L; Dubois M; That HT; Payen JL; Duffaut M; Durand D; Suc JM; Puel J
    J Infect Dis; 1997 Dec; 176(6):1614-7. PubMed ID: 9395376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C.
    Huraib S; Iqbal A; Tanimu D; Abdullah A
    Am J Nephrol; 2001; 21(6):435-40. PubMed ID: 11799259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
    Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R
    Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis.
    Mogahed EA; Abdelaziz H; Helmy H; Ghita H; Abdel Mawla MA; Hassanin F; Fadel FI; El-Karaksy H
    J Interferon Cytokine Res; 2016 Dec; 36(12):681-688. PubMed ID: 27656950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pretransplant IFN-alpha therapy on interstitial fibrosis in renal allografts with hepatitis C virus infection.
    Ozdemir BH; Ozdemir FN; Sezer S; Haberal M
    Ren Fail; 2007; 29(5):615-22. PubMed ID: 17654326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C.
    Luciani G; Bossola M; Muscaritoli M; Panocchia N; Ferrante A; Nanni G; Piccioni E; Tazza L; Grillo RL; Rossi Fanelli F; Castagneto M
    J Nephrol; 2003; 16(3):417-20. PubMed ID: 12832744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.
    Deng G; Ma J; Shen S; Li Q; Peng L; Meng S; Zhou J; Wu J; Liu D
    Transplant Proc; 2016 Nov; 48(9):3120-3122. PubMed ID: 27932161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
    Potthoff A; Wiegand J; Lüth JB; Wedemeyer H; Manns MP; Tillmann HL
    Clin Nephrol; 2005 Mar; 63(3):232-5. PubMed ID: 15786827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course.
    Mahmoud IM; Sobh MA; El-Habashi AF; Sally ST; El-Baz M; El-Sawy E; Ghoneim MA
    Nephron Clin Pract; 2005; 100(4):c133-9. PubMed ID: 15855796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
    Rostaing L; Izopet J; Moussion F; Alric L; Verdier D; That HT; Duffaut M; Durand D; Puel J; Suc JM
    Nephrologie; 1997; 18(7):281-6. PubMed ID: 9496568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis.
    Amarapurkar DN; Patel ND; Kirpalani AL
    Trop Gastroenterol; 2007; 28(1):16-8. PubMed ID: 17896604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo hepatitis C in children after liver transplantation.
    McDiarmid SV; Conrad A; Ament ME; Vargas J; Martin MG; Goss JA; Busuttil RW
    Transplantation; 1998 Aug; 66(3):311-8. PubMed ID: 9721798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.